Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 11, 2022

SELL
N/A
-17,873 Closed
0 $0
Q3 2020

Nov 13, 2020

BUY
N/A
17,873 New
17,873 $74,000
Q2 2020

Aug 14, 2020

SELL
N/A
-47,230 Closed
0 $0
Q1 2020

May 15, 2020

BUY
N/A
302 Added 0.64%
47,230 $137,000
Q2 2019

Aug 09, 2019

BUY
N/A
4,381 Added 10.3%
46,928 $291,000
Q1 2019

May 14, 2019

SELL
N/A
-7,885 Reduced 15.63%
42,547 $303,000
Q4 2018

Feb 14, 2019

BUY
N/A
1,890 Added 3.89%
50,432 $431,000
Q3 2018

Nov 13, 2018

SELL
N/A
-315 Reduced 0.64%
48,542 $972,000
Q2 2018

Aug 08, 2018

BUY
N/A
13,367 Added 37.66%
48,857 $1.26 Million
Q1 2018

May 07, 2018

BUY
N/A
4,800 Added 15.64%
35,490 $849,000
Q4 2017

Jan 17, 2018

BUY
N/A
3,218 Added 11.71%
30,690 $1.04 Million
Q3 2017

Nov 13, 2017

BUY
N/A
27,472
27,472 $582,000

About Adamas Pharmaceuticals, Inc.


  • Ticker ADMS
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 45,408,100
  • Market Cap $376M
More about ADMS
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.